INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc - GSK
KSNT 27 Newsarrow_outwardGSK ACTIVE INVESTIGATION: Lost Money on GSK plc? Contact Levi & Korsinsky Now
WTRFarrow_outwardINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc โ GSK
BigCountryHomepage.comarrow_outwardGSK Enhances Shareholder Value with Strategic Share Buyback - TipRanks
TipRanksarrow_outwardGSK Secures EU Approval as Blenrep Combinations Redefine Multiple Myeloma Care - geneonline.com
Geneonline.comarrow_outwardGlaxoSmithKline plc (GSK.L) stock price, news, quote and history - uk.finance.yahoo.com
Uk.finance.yahoo.comarrow_outwardHadley plans new quarter at former GSK HQ - Green Street News
Green Street Newsarrow_outwardINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc โ GSK - FinancialContent
FinancialContentarrow_outwardINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc - GSK - PR Newswire
PR Newswirearrow_outward2 Minute Medicine: Pharma Roundup โ Landmark lung approval, billion-dollar obesity drug deal, oncology safety halt, and GSKโs China push [August 14 2025] - 2 Minute Medicine
2 Minute Medicinearrow_outwardEli Lilly and GSK drive South Koreaโs drug licensing activity - Pharmaceutical Technology
Pharmaceutical Technologyarrow_outwardGSK to Receive $370 Million in U.S. Patent Litigation Settlement - The Wall Street Journal
The Wall Street Journalarrow_outwardGSK collects $320M as BioNTech, Pfizer settle mRNA patent spat with CureVac - Fierce Pharma
Fierce Pharmaarrow_outwardCureVac and GSK to receive money and royalties from BioNTech/Pfizer as part of mRNA patent settlement - Endpoints News
Endpoints Newsarrow_outwardPipeline progress - GSK
GSKarrow_outwardGSK to Inject โTens of Billionsโ in US Amid Trumpโs Tariffs, Pipeline Reshuffles - BioSpace
BioSpacearrow_outwardGSK pays $500M to enter drugmaking alliance with Hengrui - BioPharma Dive
BioPharma Divearrow_outwardGSK to pay Hengrui US$12.5 billion for global rights to 12 drug projects - South China Morning Post
South China Morning Postarrow_outwardGSK pays $500M upfront for rights to series of Hengrui drugs - statnews.com
Statnews.comarrow_outwardHengrui Shares Jump on GSK Deal Worth Up To $12 Billion - Bloomberg.com
Bloomberg.comarrow_outwardBreakingviews - GSK revenue hole raises chances of risky M&A move - Reuters
Reutersarrow_outwardGSK made the biggest climate promise in pharma. Can it keep it? - Trellis Group (formerly GreenBiz)
Trellis Group (formerly GreenBiz)arrow_outwardGSK blood cancer drug reapproved by EU regulator - Financial Times
Financial Timesarrow_outwardBiopharmaceutical company GSK to lay off 150 Massachusetts workers - Wicked Local
Wicked Localarrow_outwardGSK to let go of 150 jobs in Massachusetts - FirstWord Pharma
FirstWord Pharmaarrow_outwardGSK telegraphs 'very limited number' of job cuts amid R&D investment spree - Fierce Biotech
Fierce Biotecharrow_outwardGSK Stock Rises Almost 22% in 6 Months: Time to Buy, Sell or Hold? - Yahoo Finance
Yahoo Financearrow_outwardASCO 2025: GSKโs Jemperli fails to show OS benefit in 1L advanced ovarian cancer - Clinical Trials Arena
Clinical Trials Arenaarrow_outwardGSK to Acquire Efimosfermin | News - Cleary Gottlieb
Cleary Gottliebarrow_outwardSpurring Innovation: Shapiro Administration Celebrates Historic Investment in GSKโs Growth in Pennsylvania - PA Department of Community & Economic Development (.gov)
PA Department of Community & Economic Development (.gov)arrow_outwardGSKโs Kim Branson on driving innovation with AI and machine learning - McKinsey & Company
McKinsey & Companyarrow_outwardGSK could double CEO Emma Walmsleyโs pay to $27 million in bid to bring U.K. exec salaries in line with the U.S. - Fortune
Fortunearrow_outward
Gsk close
- 2025-08-20 20:40 event
- 32 sourceslanguage
- 200+ ads_click
- 2 weeks ago schedule